info@tajpharma.com +91 84484 44095 / 8071 555 357

Vapi, Gujarat, India WHO-GMP Certified

Dolutegravir Tablets Manufacturer in Vapi, Gujarat - State-of-the-Art Facility

WHO-GMP Certified

Pan-India Supply

Export Quality

Quick Inquiry

Located in the pharmaceutical hub of Vapi, Gujarat, Taj Pharmaceuticals operates a world-class manufacturing facility for Dolutegravir tablets. Vapi strategic location provides excellent connectivity and access to quality raw materials.

Why Choose Taj Pharma?

Strategic Location: Vapi is a major pharmaceutical manufacturing hub in India.
Infrastructure: Modern facility with advanced manufacturing equipment.
Skilled Workforce: Access to trained pharmaceutical professionals.
Logistics Advantage: Excellent connectivity to major ports and cities.

Product Specifications

Facility specifications meet international standards with modern infrastructure.

Manufacturing Excellence

Manufacturing Facility

50,000 sq ft facility in GIDC Vapi with dedicated production lines for Dolutegravir tablets.

Supply & Distribution Network

Strategic location enables efficient distribution across India and export markets.

Quality Certifications

WHO-GMP

WHO-GMP

EU-GMP

EU-GMP PICs

GMP

GMP Certified

Quality

Quality Excellence

Facility holds multiple certifications including WHO-GMP and EU-GMP.

Frequently Asked Questions

Vapi offers excellent infrastructure, skilled workforce, and strategic connectivity.

Our Vapi facility spans over 50,000 sq ft with dedicated production areas.

Ready to Order Dolutegravir Tablets?

Contact us today for competitive pricing and bulk order discounts

Contact Us Call Now

Related Information

Explore more about our products and services

View Products

Browse our complete range of Dolutegravir tablets and pharmaceutical products.

Get Quote

Request a competitive quote for your bulk orders with flexible payment terms.

FAQ

Find answers to frequently asked questions about our products and services.

Blog

Read articles about HIV treatment, Dolutegravir, and pharmaceutical industry updates.